newsfilter
← Latest News
ClinicalTrials.gov·

Dose Escalation of SNK-396 in Participants With Elevated Low-Density Lipoprotein Cholesterol - NCT05896969

Treatment emergent adverse events, Pharmacokinetic Assessment, Pharmacodynamic (PD) effect assessment